间充质干细胞来源的小细胞外囊泡在青光眼啮齿动物模型中促进神经保护
研究探讨骨髓间充质干细胞(BMSC)来源的小细胞外囊泡(sEV)作为玻璃体内注射疗法在两种大鼠青光眼模型中的获益,并鉴定参与机制的候选miRNA。结果显示BMSC来源sEV可显著保护视网膜神经节细胞(RGC),防止视网膜神经纤维层(RNFL)变薄和正暗视阈值反应(pSTR)丢失,每周或每月注射有效,间隔更长则无效;敲低Argonaute2(AGO2)可显著减弱上述效应。
要点
- BMSC来源sEV玻璃体内注射可显著保护RGC,防止RNFL变薄和pSTR丢失。
- 每周或每月注射sEV治疗有效,治疗间隔更长则无效。
- 敲低AGO2可显著减弱sEV的神经保护效应。
核心结论
- 玻璃体内注射BMSC来源sEV对青光眼眼提供显著治疗获益。
- sEV的神经保护效应至少部分可能通过miRNA依赖机制直接作用于RGC来解释。
研究设计与样本
- 从人BMSC和成纤维细胞分离sEV,在成年大鼠眼压升高后行玻璃体内注射。
- 眼压升高采用前房内注射微珠或激光光凝周缘角膜缘血管及小梁网两种方法。
- 采用光学相干断层扫描测量RNFL厚度,ERG记录pSTR,视网膜铺片计数RBPMS+ RGC,RNAseq测序sEV miRNA。
主要发现
- BMSC来源sEV促进RGC显著神经保护,防止RNFL退行性变薄和pSTR丢失。
- sEV每周或每月玻璃体内注射治疗有效,治疗间隔更长则无效。
- 分离sEV前敲低AGO2可显著减弱上述效应。
- 加入BMSC sEV(而非成纤维细胞sEV)减少培养的纯化RGC死亡。
- RNAseq鉴定出BMSC sEV相比无神经保护作用的成纤维细胞sEV有43个miRNA上调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the benefit of bone marrow mesenchymal stem cell (BMSC)-derived small extracellular vesicles (sEV) as an intravitreal (ivit) therapy in two rat models of glaucoma and to determine and identify candidate miRNA involved in the mechanism. METHODS: sEV were isolated from human BMSC and fibroblasts and ivit injected into adult rats after induction of elevated IOP. IOP was elevated using either intracameral injection of microbeads or laser photocoagulation of circumferential limbal vessels and the trabecular meshwork. Retinal nerve fiber layer (RNFL) thickness was measured using optical coherence tomography, positive scotopic threshold response (pSTR) recorded using ERG, and RNA binding protein with multiple splicing (RBPMS+) retinal ganglion cell (RGC) counted using retinal wholemounts. sEV miRNA were sequenced using RNAseq. RESULTS: sEV isolated from BMSC promoted significant neuroprotection of RGC while preventing RNFL degenerative thinning and loss of pSTR. sEV proved therapeutically efficacious when ivit injected every week or every month, but ineffective with longer delays between treatments. Knockdown of Argonaute2 (AGO2), a protein critical for miRNA function and packing into sEV prior to sEV isolation, significantly attenuated the above effects. Addition of BMSC sEV (but not fibroblast sEV) reduced death of cultured purified RGC. RNAseq identified 43 miRNA upregulated in BMSC sEV in comparison to fibroblast sEV, which yielded no neuroprotective effects. CONCLUSIONS: Injection of BMSC-derived sEV into the vitreous provided significant therapeutic benefit to glaucomatous eyes. The neuroprotective effect of sEV, at least partially, may be explained by direct action on RGC through miRNA-dependent mechanisms.
引用
- Mead B, Amaral J, Tomarev S, et al. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma. Invest Ophthalmol Vis Sci. 2018. PMID: 29392316. doi:10.1167/iovs.17-22855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。